PGE(2) contributes to TGF-beta induced T regulatory cell function in human non-small cell lung cancer. - Wikidata - awgldk - TriplyDB

PGE(2) contributes to TGF-beta induced T regulatory cell function in human non-small cell lung cancer.

PGE(2) contributes to TGF-beta induced T regulatory cell function in human non-small cell lung cancer.

http://www.wikidata.org/entity/Q34073958

about

Predictive factors of activity of anti-programmed death-1/programmed death ligand-1 drugs: immunohistochemistry analysis Inflammatory response, immunosuppression, and cancer recurrence after perioperative blood transfusions The Multifaceted Roles Neutrophils Play in the Tumor Microenvironment Regulation of COX2 expression in mouse mammary tumor cells controls bone metastasis and PGE2-induction of regulatory T cell migration.Quantification of active and total transforming growth factor-β levels in serum and solid organ tissues by bioassay Novel antibody against a glutamic acid-rich human fibrinogen-like protein 2-derived peptide near Ser91 inhibits hfgl2 prothrombinase activity Tetrandrine identified in a small molecule screen to activate mesenchymal stem cells for enhanced immunomodulation Morphoproteomics provides support for TGF-β pathway signaling in the osteoclastogenesis and immune dysregulation of osteolytic Langerhans cell histiocytosis.Lung cancer: Biology and treatment options.Repurposing Drugs in Oncology (ReDO)-diclofenac as an anti-cancer agent Naringenin prevents TGF-β1 secretion from breast cancer and suppresses pulmonary metastasis by inhibiting PKC activation.Mycobacteria-responsive sonic hedgehog signaling mediates programmed death-ligand 1- and prostaglandin E2-induced regulatory T cell expansion.Immunotherapy: shifting the balance of cell-mediated immunity and suppression in human prostate cancer.How numbers, nature, and immune status of foxp3(+) regulatory T-cells shape the early immunological events in tumor development The Immunoregulatory Potential of Particle Radiation in Cancer Therapy.Phase I Trial of Intratumoral Injection of CCL21 Gene-Modified Dendritic Cells in Lung Cancer Elicits Tumor-Specific Immune Responses and CD8+ T-cell Infiltration.Human Articular Chondrocytes Regulate Immune Response by Affecting Directly T Cell Proliferation and Indirectly Inhibiting Monocyte Differentiation to Professional Antigen-Presenting Cells.IL-10 production in non-small cell lung carcinoma patients is regulated by ERK, P38 and COX-2.Contribution of Adipose Tissue to Development of Cancer.Prostaglandin E2 Antagonizes TGF-β Actions During the Differentiation of Monocytes Into Dendritic Cells.

P2860

Q26769728-DFAC89C3-430B-4550-814B-19EBC3E928B3 Q27023584-C0F937C6-A0D6-4320-BBEA-D4C078B2D2E6 Q28241308-95E83818-7132-444B-9FF9-DFA413C101D8 Q34431108-49859B87-C79C-422C-BA98-2E2AC11281AD Q34476894-3C1D44E3-0B28-48C1-BBFE-46FF955AB4D0 Q35146839-097BAE53-119B-44AB-A77A-EE982FF3C7A4 Q36085591-95E1AAF1-75B2-4F3A-B8CB-3EC028CCC7AC Q36196768-BF76CF12-6A94-453C-AFC0-20B38CE988B4 Q36328370-F11B025D-BE04-435E-9AEE-ADA318FDACF6 Q36483712-DD021E00-1421-4577-A131-B81F5D85C61F Q36758301-E24EE69F-13E5-402F-A3E5-794E18233432 Q36799500-16AE660A-FFE7-43A8-A2A6-34E66691E522 Q37017085-017B5590-C5DB-4858-ACFC-308AB67068B6 Q37199750-B1CC7A86-8CAF-4BA0-B199-31453D302D3E Q37625801-104E2CCB-6758-4C48-B3FB-8FED4467B40C Q38688006-BC9BDAC3-E4E9-4047-9E3B-7E499983D7A6 Q41542925-02CEDD2B-6081-42C3-A117-B2713011DA4A Q42914474-CFDD1C19-F882-46B4-80E5-D71575D35329 Q49164235-BD7542C4-344D-4564-A694-EF397B9EB162 Q55456463-DB2E491D-8FA5-4FCB-B404-2620BC270548

P2860

PGE(2) contributes to TGF-beta induced T regulatory cell function in human non-small cell lung cancer.

http://www.wikidata.org/entity/Q34073958

description

2010 nî lūn-bûn

@nan

2010 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

PGE(2) contributes to TGF-beta ...... an non-small cell lung cancer.

@ast

PGE(2) contributes to TGF-beta ...... an non-small cell lung cancer.

@en

type

label

PGE(2) contributes to TGF-beta ...... an non-small cell lung cancer.

@ast

PGE(2) contributes to TGF-beta ...... an non-small cell lung cancer.

@en

prefLabel

PGE(2) contributes to TGF-beta ...... an non-small cell lung cancer.

@ast

PGE(2) contributes to TGF-beta ...... an non-small cell lung cancer.

@en

P1433

Q34073958-D64AF1B9-78F9-4C49-89FD-51158DB8A0C2

P1476

Q34073958-DCB1F96D-B887-4DDA-B71A-85A73F2DA9A6

P2093

Q34073958-0455FC0C-3540-4A33-BB6C-D8EC6B2B3FF3

Q34073958-1F5E32C4-F124-4D5E-9E87-DB0C7139BCAA

Q34073958-368E02BE-DD5B-4BFD-993E-130B008D5373

Q34073958-4E603D1A-D01F-499E-A9D4-7AAB9E1F7E33

Q34073958-4FAB0EBF-330A-4632-AC82-CC64205D9462

Q34073958-5723DEE2-CEB1-4629-9B4A-FCC7180803D8

Q34073958-6B36447D-857E-4C19-BE61-D3B85990BBC8

Q34073958-7187AA03-C8BA-437A-B4BA-1FAA2DAE42C1

Q34073958-AFCDE488-A86B-48B6-8575-066E8DCC066B

Q34073958-B16D1820-F1B6-4506-8870-3F14C3150FB7

P2860

Q34073958-17F9CAA6-6C4E-42E8-BEFB-C7D077CEBF48

Q34073958-1AF2D6E3-533F-4758-B4F2-607FBDB3C67E

Q34073958-1D4E868E-B618-4E46-9016-54DC0E21C9EB

Q34073958-1F647632-6BD7-4A5C-AC38-59ED27CEA9E6

Q34073958-3B8D4947-1F59-4075-B3F3-68ECE7DD7534

Q34073958-3F338C76-C14E-44C5-80A1-F8CA4DCF6121

Q34073958-42E5777F-2993-4810-87E5-F7641BB382F7

Q34073958-4411F731-3548-43BD-90FF-CE188780E986

Q34073958-453DCC90-EA1E-4BAC-87A3-2777EB416CD7

Q34073958-455762E3-2B7F-439F-B9A3-4F23AE47522A

P304

Q34073958-EC7BDE66-1BE9-4044-8DB0-0F414AB61FC7

P31

Q34073958-2FC4AEF4-8D2A-4F34-A68A-48F7D45F13ED

P407

Q34073958-85E2D5BE-DEE7-427C-ACCC-C4632F813D12

P433

Q34073958-6C8BA72E-CB9B-4842-B214-F1516256B973

P478

Q34073958-BBEE835A-0DC8-43C9-8E02-0B75EEE3846E

P577

Q34073958-64C2D45B-A4A4-413B-9D1A-1C2374477D88

P698

Q34073958-6CC2062E-7B09-4E84-B64E-4E8A332CAAE0

P932

Q34073958-2717AB00-EE52-4D5E-BE07-D78C0CC5B9DA

P1433

American Journal of Translational Research

P1476

PGE(2) contributes to TGF-beta ...... an non-small cell lung cancer.

@en

P2093

David Elashoff

http://www.w3.org/2001/XMLSchema#string

Dorthe Schaue

http://www.w3.org/2001/XMLSchema#string

Felicita Baratelli

http://www.w3.org/2001/XMLSchema#string

Jay M Lee

http://www.w3.org/2001/XMLSchema#string

Karen Reckamp

http://www.w3.org/2001/XMLSchema#string

Ling Zhang

http://www.w3.org/2001/XMLSchema#string

Michael C Fishbein

http://www.w3.org/2001/XMLSchema#string

Peter S Pak

http://www.w3.org/2001/XMLSchema#string

Saswati Hazra

http://www.w3.org/2001/XMLSchema#string

Sherven Sharma

http://www.w3.org/2001/XMLSchema#string

P2860

Cutting edge: TGF-beta induces a regulatory phenotype in CD4+CD25- T cells through Foxp3 induction and down-regulation of Smad7

Cancer statistics, 2009

Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

Mechanisms of foxp3+ T regulatory cell-mediated suppression

New insights into the regulation of T cells by gamma(c) family cytokines

The role of TGFbeta in human cancers.

Regulatory CD4(+)CD25(+) T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer.

Increase of regulatory T cells in the peripheral blood of cancer patients.

IL-2- and CD25-dependent immunoregulatory mechanisms in the homeostasis of T-cell subsets.

The tumor microenvironment: a potential arbitrator of the tumor suppressive and promoting actions of TGFbeta.

P304

356-367

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P577

2010-06-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20733946

http://www.w3.org/2001/XMLSchema#string

P932

2923860

http://www.w3.org/2001/XMLSchema#string